+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Airway/Lung Stents - Global Strategic Business Report

  • PDF Icon

    Report

  • 278 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 4845877
The global market for Airway/Lung Stents was estimated at US$216.3 Thousand in 2025 and is projected to reach US$349.0 Thousand by 2032, growing at a CAGR of 7.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Airway/Lung Stents Market - Key Trends & Drivers Summarized

What Are Airway/Lung Stents and Why Are They Essential for Respiratory Care?

Airway or lung stents are vital medical devices designed to maintain open passages in the respiratory tract, particularly in patients with conditions like chronic obstructive pulmonary disease (COPD), lung cancer, or tracheobronchial obstructions. These stents, made from materials like metal or silicone, are used to prevent airway collapse, helping patients breathe more easily and improving their overall quality of life. Airway stents are especially important for individuals who are not suitable candidates for surgery or where conventional treatments like medications are insufficient to manage severe respiratory obstructions. As the incidence of respiratory diseases continues to rise globally, the role of airway stents in patient care becomes even more critical.

How Are Technological Innovations Revolutionizing Airway Stent Design?

Technological advancements have significantly improved the design and functionality of airway/lung stents. Traditional silicone stents, valued for their removability and flexibility, are now complemented by metal stents, which offer superior durability and long-term structural support. More recently, hybrid stents have emerged, combining the benefits of both materials. Additionally, innovations such as drug-eluting stents, which slowly release medication to prevent infections or inflammation, have greatly reduced post-procedural complications. Imaging and navigation technologies have also improved the precision of stent placement, reducing the risk of stent migration or misplacement. These advancements are driving improved outcomes in patients undergoing stent placement.

What Is Driving the Increased Demand for Airway/Lung Stents?

The global demand for airway stents is steadily increasing due to several factors, including the rising prevalence of respiratory diseases such as COPD, lung cancer, and asthma. Air pollution, smoking, and aging populations have contributed to a surge in these conditions, necessitating the use of airway stents in critical care. Additionally, there is growing awareness among healthcare professionals and patients about the effectiveness of airway stents as a minimally invasive option to manage airway obstruction. This has led to the adoption of stenting procedures not only in emergency situations but also in long-term palliative care for patients with terminal illnesses.

What Factors Are Driving Growth in the Airway/Lung Stents Market?

The growth in the airway/lung stents market is driven by several factors, including advancements in stent materials and designs, the increasing prevalence of chronic respiratory diseases, and the growing demand for minimally invasive treatments. Technological innovations such as drug-eluting stents and improved imaging techniques are enhancing treatment outcomes and patient safety, contributing to market growth. The rising incidence of COPD and lung cancer, particularly in aging populations and regions with high air pollution, is increasing the need for airway stents. Additionally, improved access to healthcare in developing regions is expanding the adoption of these critical devices.

Report Scope

The report analyzes the Airway/Lung Stents market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Material Type (Metal, Silicone, Hybrid); Product (Self-Expandable, Balloon-Expandable, Non-Expandable); Type (Tracheal, Laryngeal).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Self-Expandable Stents Product segment, which is expected to reach US$164.2 Thousand by 2032 with a CAGR of 7.2%. The Balloon-Expandable Stents Product segment is also set to grow at 5.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $63.3 Thousand in 2025, and China, forecasted to grow at an impressive 6.8% CAGR to reach $61.8 Thousand by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Airway/Lung Stents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Airway/Lung Stents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Airway/Lung Stents Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Becton, Dickinson Company, Boston Scientific Corporation, Changzhou Health Microport Medical Device Co., Ltd., Cook Group, Inc., EFER Endoscopy and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Airway/Lung Stents market report include:

  • Becton, Dickinson Company
  • Boston Scientific Corporation
  • Changzhou Health Microport Medical Device Co., Ltd.
  • Cook Group, Inc.
  • EFER Endoscopy
  • ENDO-FLEX GmbH
  • Fuji Systems Corporation
  • Hood Laboratories, Inc.
  • Merit Medical Systems, Inc.
  • Teleflex, Inc.

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 1,182 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Airway/Lung Stents - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Respiratory Diseases Driving Stent Demand
  • Technological Advancements in Self-Expanding and Drug-Eluting Stents
  • Increased Focus on Minimally Invasive Treatment Options for Lung Obstructions
  • Growing Awareness Among Physicians and Patients About Airway Stents
  • Development of Biodegradable Stents for Temporary Airway Support
  • Rising Demand for Customized Stents for Complex Airway Conditions
  • Expansion of Stent Use in Palliative Care for Advanced-Stage Cancer Patients
  • Improved Precision in Stent Placement with Advanced Imaging Technologies
  • Increasing Use of Stents in Bronchoscopic Procedures for Lung Cancer
  • Growth in Healthcare Infrastructure in Developing Regions Boosting Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Airway/Lung Stents Market Analysis of Annual Sales in US$ for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Airway/Lung Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Airway/Lung Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Airway/Lung Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Self-Expandable Stents Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Self-Expandable Stents Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Self-Expandable Stents Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Balloon-Expandable Stents Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Balloon-Expandable Stents Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Balloon-Expandable Stents Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Non-Expandable / Customized 3D-Printed Stents Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Non-Expandable / Customized 3D-Printed Stents Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Non-Expandable / Customized 3D-Printed Stents Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Metal Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Metal Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Metal Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Silicone Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Silicone Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Silicone Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Hybrid Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Hybrid Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Hybrid Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Bioresorbable Polymers Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Bioresorbable Polymers Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Bioresorbable Polymers Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Malignant Central Airway Obstruction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Malignant Central Airway Obstruction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Malignant Central Airway Obstruction Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Benign Tracheal Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Benign Tracheal Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Benign Tracheal Stenosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Post-Lung-Transplant Airway Complications Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Post-Lung-Transplant Airway Complications Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Post-Lung-Transplant Airway Complications Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Tracheoesophageal Fistula Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Tracheoesophageal Fistula Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Tracheoesophageal Fistula Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 44: World Recent Past, Current & Future Analysis for Specialty Pulmonology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • Table 45: World Historic Review for Specialty Pulmonology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • Table 46: World 13-Year Perspective for Specialty Pulmonology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Airway/Lung Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLD
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton, Dickinson Company
  • Boston Scientific Corporation
  • Changzhou Health Microport Medical Device Co., Ltd.
  • Cook Group, Inc.
  • EFER Endoscopy
  • ENDO-FLEX GmbH
  • Fuji Systems Corporation
  • Hood Laboratories, Inc.
  • Merit Medical Systems, Inc.
  • Teleflex, Inc.

Table Information